Bacterial infections that may lead to sepsis in patients is a major problem in many aspects of hospital care, including emergency medicine, transplant surgery, and intensive care.1 To combat these infections, current medical practice calls for the use of broad spectrum antibiotics until bacterial cultures can identify specific pathogens. Because of the doubling time of bacteria, this process may take 48 to 96 h. There are also well-known drawbacks to broad spectrum antibiotic use, such as increased antibiotic resistance, costs, and toxicity.2 Furthermore, some outbreaks involve bacteria that are resistant to standard broad spectrum coverage, and delays in diagnosis may result in more advanced disease.